FDA Approves Linagliptin Tablets For The Treatment Of Type 2 Diabetes
Links shared publicly online about this topic.
- 320total visits
FDA Approves Linagliptin Tablets For The Treatment Of Type 2 Diabetes
View full resource at medicalnewstoday.com
Tags: Diabetes, Type 2 Diabetes, Diet and Nutrition, Drug, FDA, Eli Lilly and Company, Boehringer Ingelheim
Most Recently Shared on May 4, 2011 at 1:57 am By:
FDA Approves Linagliptin Tablets For The Treatment Of Type 2 Diabetes: Boehringer Ingelheim and Eli Lilly and Co... http://bit.ly/lW6XKy
Also Shared By:
FDA approves extended-release tablets for type 2 diabetes - - Drug Topics
drugtopics.modernmedicine.com — “FDA approved sitagliptin and metformin hydrochloride (HCl) extended-release (Janumet XR, Merck) tablets, a new treatment for type 2 diabetes that combines sitagliptin, which is the active component of Januvia (sitagliptin), with extended-release metformin.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on February 6, 2012 at 2:13 am By:
FDA approves extended-release tablets for type 2 diabetes: FDA approved sitagliptin and metformin hydrochloride ... http://t.co/5Kio7lsL
Boehringer Ingelheim, Lilly receive FDA approval for Jentadueto to treat type 2 diabetes
news-medical.net — “Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) has approved Jentadueto (linagliptin/metformin hydrochloride) tablets, a new tablet combining the dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, and metformin.” View full resource at news-medical.net
Most Recently Shared on January 31, 2012 at 12:29 pm By:
Boehringer Ingelheim, Lilly receive FDA approval for Jentadueto to treat type 2 diabetes: Boehringer Ingelheim P... http://t.co/QrEPkXXO
EMA CHMP recommends approval of linagliptin for type 2 diabetes
news-medical.net — “Boehringer Ingelheim and Eli Lilly and Company today received a positive opinion from the European Medicines Agency's (EMA) medicinal committee recommending approval of linagliptin, 5 mg, film-coated tablets (to be marketed under the trade name Trajenta® in Europe) for the treatment of adults with type 2 diabetes.” View full resource at news-medical.net
Most Recently Shared on June 24, 2011 at 8:47 pm By:
EMA CHMP recommends approval of linagliptin for type 2 diabetes: Boehringer Ingelheim and Eli Lilly and Company ... http://bit.ly/kjFU5X
FDA Approves Tradjenta™ (linagliptin) Tablets for the Treatment of Type 2 Diabetes : FDA Approves Tradjenta™ (linagliptin) Tablets for the Treatment of Type 2 Diabetes
dlife.com — “FDA Approves Tradjenta™ (linagliptin) Tablets for the Treatment of Type 2 Diabetes : FDA Approves Tradjenta™ (linagliptin) Tablets for the Treatment of Type 2 Diabetes” View full resource at dlife.com
Most Recently Shared on May 4, 2011 at 1:57 am By:
FDA Approves Tradjentaâ„¢ (linagliptin) Tablets for the Treatment of Type 2 Diabetes: read more (Source: Diabete... http://bit.ly/mg0OL5
Tradjenta (linagliptin) Tablets For Diabetes Type 2 Approved By FDA
medicalnewstoday.com — “The FDA has approved Tradjenta (linagliptin) tablets to control blood sugar in adults with diabetes type two - to be used along with diet and exercise, Boehringer Ingelheim Pharmaceuticals, Inc. a” View full resource at medicalnewstoday.com
Most Recently Shared on May 4, 2011 at 1:08 am By:
Tradjenta (linagliptin) Tablets For Diabetes Type 2 Approved By FDA: The FDA has approved Tradjenta (linagliptin... http://bit.ly/kwMtjw
Tradjenta (linagliptin) Tablets For Diabetes Type 2 Approved By FDA
medicalnewstoday.com — “The FDA has approved Tradjenta (linagliptin) tablets to control blood sugar in adults with diabetes type two - to be used along with diet and exercise, Boehringer Ingelheim Pharmaceuticals, Inc. a” View full resource at medicalnewstoday.com
Most Recently Shared on May 3, 2011 at 9:05 pm By:
MNT Drug Approvals Health News
Tradjenta (linagliptin) Tablets For Diabetes Type 2 Approved By FDA http://mnt.to/3Vmq #regulatory
PharmaLive: FDA Approves Tradjenta (linagliptin) Tablets for the Treatment of Type 2 Diabetes
pharmalive.com — “PharmaLive: FDA Approves Tradjenta (linagliptin) Tablets for the Treatment of Type 2 Diabetes” View full resource at pharmalive.com
Most Recently Shared on May 3, 2011 at 7:58 pm By:
FDA Approves Tradjenta (linagliptin) Tablets for the Treatment of Type 2 Diabetes (PhamaLive) http://bit.ly/lJL8JC
FDA Approves Tradjenta(TM) (linagliptin) for Treatment of Type 2 Diabetes
disabled-world.com — “U.S. Food and Drug Administration has approved Tradjenta (linagliptin) tablets a prescription medication used along with diet and exercise to lower blood sugar in adults with type 2 diabetes” View full resource at disabled-world.com
Most Recently Shared on May 3, 2011 at 7:03 pm By:
Disabled World Health News and Health Advocate
FDA Approves Tradjenta(TM) (linagliptin) for Treatment of Type 2 Diabetes http://ff.im/-Cz1bO
Tradjenta Approved for Type 2 Diabetes - MPR
empr.com — “Boehringer Ingelheim and Eli Lilly announced that the FDA has approved Tradjenta (linagliptin tablets), a dipeptidyl peptidase-4 (DPP-4) inhibitor, as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.” View full resource at empr.com
Most Recently Shared on May 3, 2011 at 2:38 pm By:
MPR News: Tradjenta Approved for Type 2 Diabetes: Boehringer Ingelheim and Eli Lilly announced that the FDA has ... http://bit.ly/iYELgu
Tradjenta Approved for Type 2 Diabetes - ONA
oncologynurseadvisor.com — “Boehringer Ingelheim and Eli Lilly announced that the FDA has approved Tradjenta (linagliptin tablets), a dipeptidyl peptidase-4 (DPP-4) inhibitor, as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 3, 2011 at 2:07 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Tradjenta Approved for Type 2 Diabetes http://goo.gl/fb/XQTFl
FDA Approves Tradjenta™ (linagliptin) Tablets for the Treatment of Type... -- RIDGEFIELD, Conn. and INDIANAPOLIS, May 2, 2011 /PRNewswire/ --
prnewswire.com — “FDA Approves Tradjenta™ (linagliptin) Tablets for the Treatment of Type 2 Diabetes. First DPP-4 inhibitor approved at one dosage strength; no dose adjustment recommended for patients with type 2 diabetes who have kidney or liver impairment.” View full resource at prnewswire.com
Most Recently Shared on May 2, 2011 at 10:52 pm By:
FDA Approves Tradjenta™ (linagliptin) Tablets for the Treatment of Type 2 #Diabetes http://prn.to/kR9D03
Eli Lilly and Company - FDA Approves Tradjenta™ (linagliptin) Tablets for the Treatment of Type 2 Diabetes
newsroom.lilly.com — “Eli Lilly and Company - FDA Approves Tradjenta™ (linagliptin) Tablets for the Treatment of Type 2 Diabetes” View full resource at newsroom.lilly.com
Most Recently Shared on May 2, 2011 at 10:51 pm By:
Hope Warshaw Dietitian and Nutritionist
Looks like FDA approved Lilly/Boehringer Ingelheim's DPP-4 linagliptin/Tradjenta today 5/2. Read Lilly press release: http://bit.ly/jtGvcz
Kombiglyze XR tablets approved for the treatment of type 2 diabetes mellitus in adults - - Drug Topics
drugtopics.modernmedicine.com — “FDA has approved saxagliptin and metformin extended-release (XR) (Kombiglyze XR, AstraZeneca/Bristol-Myers Squibb) tablets for the treatment of type 2 diabetes in adults. Kombiglyze XR is the first and only once-a-day metformin XR plus dipeptidyl peptidase-4 (DPP-4) inhibitor combination tablet offering strong glycemic control across glycosylated hemoglobin levels, fasting plasma glucose, and postprandial glucose.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on November 12, 2010 at 2:02 pm By:
Kombiglyze XR tablets approved for the treatment of type 2 diabetes mellitus in adults: FDA has approved saxagli... http://bit.ly/cIZrir
KOMBIGLYZE™ XR Tablets Approved In The US For The Treatment Of Type 2 Diabetes Mellitus In Adults
medicalnewstoday.com — “AstraZeneca and Bristol-Myers Squibb Company announced that the US Food and Drug Administration (FDA) approved KOMBIGLYZE™ XR for the treatment of type 2 diabetes in adults. KOMBIGLYZE XR i” View full resource at medicalnewstoday.com
Most Recently Shared on November 10, 2010 at 4:05 pm By:
KOMBIGLYZE™ XR Tablets Approved In The US For The Treatment Of Type 2 Diabetes Mellitus In Adults http://mnt.to/3Mm3 #diabetes
Advertisement
MNT Drug Approvals
@mnt_drugapprov
KOMBIGLYZE™ XR Tablets Approved In The US For The Treatment Of Type 2 Diabetes Mellitus In Adults http://mnt.to/3Mm3 #regulatory
1 year ago...